Point-of-Care Diagnostics Market

Point-of-Care Diagnostics Market (Product: Infectious Disease Testing Products, Glucose Monitoring Products, Cardiometabolic Monitoring Products, Pregnancy & Fertility Testing Products, Coagulation Monitoring Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products and Others; Technology: Biochemistry, Immunoassay and Molecular Diagnostics) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2026–2036

Point-of-Care Diagnostics Market Outlook 2036

The global point-of-care diagnostics market size was valued at USD 19.1 Billion in 2025 and is projected to reach USD 43.7 Billion by 2036, expanding at a CAGR of 7.8% from 2026 to 2036. The global market is driven by the rising prevalence of chronic and infectious diseases, along with the growing demand for rapid, decentralized testing in hospitals, clinics, and home-care settings. Additionally, technological advancements in portable diagnostic devices and increasing adoption of home-based healthcare solutions are further accelerating market growth.

Market Size & Highlights

  • The point-of-care diagnostics market reached USD 19.1 Billion in 2025.
  • The market is expected to climb to USD 43.7 Billion by 2036.
  • The point-of-care diagnostics industry is anticipated to expand at a CAGR of 7.8% from 2026 to 2036.
  • Major companies in the market include Abbott, BD, Bio-Rad Laboratories, Inc., bioMérieux SA, Cardinal Health Inc., Danaher Corporation etc.
  • North America dominated the market in 2025, holding the largest revenue share of 42.3%
  • By Mode of Purchase, OTC Products accounted for the largest market share of 62.5% in 2025

Point Of Care Diagnostics Market By Revenue

Analysts’ Viewpoint

The point-of-care (PoC) diagnostics market is witnessing steadiness as healthcare systems increasingly focus on rapid diagnosis, early disease detection, and decentralized care delivery. PoC diagnostics are becoming a vital component of modern healthcare as they provide immediate results that enable doctors to make fast healthcare decisions without needing to depend on central laboratory systems. The current movement of healthcare systems toward values that put patients at the center of their operations shows that all healthcare systems worldwide have started to adopt this practice.

The market witnesses growth due to three main factors; which include increasing rates of both - chronic and infectious diseases, the need for fast testing during emergency and critical care situations, and the rising use of home diagnostic testing. The development of biosensors, molecular diagnostics, and microfluidics technologies has enabled PoC devices to achieve better testing accuracy, testing mobility, and testing performance.

The market faces three main constraints including high expenses of advanced PoC systems, regional markets with restricted reimbursement options, and problems about test reliability when compared to standard laboratory testing. The absence of skilled workers together with the complicated nature of regulations prevents the market from expanding.

Emerging economies present significant business opportunities as these countries develop their healthcare systems and people begin to understand the importance of early medical diagnosis. Home testing kits have gained popularity while digital health platforms create more connections amongst people, healthcare systems, and connected PoC devices that share patient data in real-time.

Point-of-Care Diagnostics Market Introduction

POC testing is also known as bedside testing, near-patient testing, remote testing, mobile testing, and rapid diagnostics. The key advantages of PoC diagnostics include reduced turnaround time, improved patient outcomes, lower healthcare costs, and enhanced accessibility, particularly in remote and resource-limited settings.

Attribute Detail
Market Drivers
  • Rising prevalence of chronic and infectious diseases, increasing the demand for rapid and early diagnosis
  • Increasing adoption of home-based testing and remote patient monitoring solutions

Rising Prevalence of Chronic and Infectious Diseases, Increasing Demand for Rapid and Early Diagnosis Expected to Drive Point-Of-Care Diagnostics Market Size

The increasing incidences of chronic and infectious diseases are bound to drive point-of-care diagnostics market growth throughout the forecast period. The requirement for swift and accurate diagnostic methods arises from the need to monitor and diagnose conditions that include diabetes, cardiovascular disorders, respiratory infections, and emerging viral diseases.

Healthcare providers can use point-of-care diagnostics to conduct testing at or near patient treatment areas, which leads to decreased test processing time and enables immediate medical decision-making. The technology plays a vital role in emergency response situations as well as primary healthcare facilities and locations with limited resources that lack central laboratory testing capabilities.

The increasing incidences of chronic conditions among older adults has increased the need for continuous monitoring equipment, which includes glucose meters and cardiac markers that healthcare providers use at point-of-care facilities. The global increase in disease cases has led healthcare providers to implement point-of-care diagnostic systems at their facilities with greater speed.

Increasing Adoption of Home-Based Testing and Remote Patient Monitoring Solutions Anticipated to Boost Point-Of-Care Diagnostics Market Expansion

The point-of-care diagnostics market is bound to experience substantial growth over the forecast period due to increasing adoption of home-based testing and remote patient monitoring solutions. Patients prefer home diagnostic solutions as they want to monitor their health continuously without visiting hospitals.

Patients can easily track their blood glucose levels, pregnancy status, cholesterol levels, and infectious diseases through home-based point-of-care tests. Patients will follow medical advice better as this approach provides direct access to medical treatment, while medical centers and testing facilities will experience decreased operational demands.

The remote patient monitoring process becomes more effective through the increasing adoption of digital health technologies together with wearable devices. Healthcare providers receive continuous patient health updates through connected point-of-care devices that transmit real-time data. The system supports chronic disease management as it allows healthcare providers to track diabetes, cardiovascular, and respiratory conditions that need ongoing observation. The need for remote diagnostic tools has grown as physicians use patient-generated data to conduct clinical assessments within the expanding telemedicine services.

Attribute Detail
Market Opportunity
  • Integration of digital health technologies, AI, and smartphone-based diagnostic platforms

Integration of Digital Health Technologies, Artificial Intelligence, and Smartphone-Based Diagnostic Platforms Presents Significant Opportunity for Point-Of-Care Diagnostics Market

The combination of digital health technologies together with artificial intelligence (AI) and smartphone diagnostic systems creates a major potential for expanding the point-of-care diagnostics market. Digital health solutions enable healthcare systems to operate their conventional diagnostic systems through real-time patient health data collection, analysis, and remote patient health information access.

Healthcare providers can use the combined technologies with point-of-care devices to achieve ongoing patient monitoring and rapid, precise clinical decision-making. AI-powered algorithms improve diagnostic accuracy by enabling automated result interpretation, risk assessment, and predictive analytics, which decrease human error possibilities.

Smartphone-based diagnostic platforms are experiencing rapid growth as they provide users with high convenience and portable diagnostic tools, which come at low prices. Users can conduct tests through mobile applications that connect to small diagnostic instruments, making healthcare services more available to people who live in distant and poorly served areas.

Patients and healthcare professionals can share data without interruptions as smartphone connectivity links their devices together, which enables them to use remote consultations and telemedicine services. The combination of these two technologies enhances patient participation while decreasing healthcare expenses as it decreases the need for hospital stays and laboratory tests. The healthcare industry is moving toward digital and connected care solutions, which will drive market expansion through AI integration and smartphone technology in point-of-care diagnostics systems.

OTC Products Segment Driving Point-of-Care Diagnostics Market Growth

Point Of Care Diagnostics Market By Type

The OTC products segment currently leads with 62.5% share of the global point-of-care diagnostics market through its purchasing methods as more consumers choose self-testing and accessible healthcare options. The development of e-Commerce platforms together with digital pharmacies has enabled people to access OTC point-of-care products throughout both urban and rural regions, which strengthens market distribution.

Technological advancements have also improved the accuracy and reliability of OTC diagnostic kits, which has increased consumer trust in self-testing solutions. The regulatory bodies from multiple countries now approve additional OTC diagnostic products, which expand the product range that end-users can access. The OTC products segment will retain its leading market position within point-of-care diagnostics as healthcare systems are moving toward patient-centric models.

Regional Outlook of Point-of-Care Diagnostics Market

Point Of Care Diagnostics Market By Region

Attribute Detail
Leading Region
  • North America

North America is the dominant region in the Point-of-Care Diagnostics Market, accounting for a considerable 42.3% market share. Point-of-care diagnostic solutions have become common throughout hospitals, clinics, ambulatory care centers, and home-care locations across the U.S. and Canada. The rising demand for quick and accurate testing solutions in the region results from the increasing number of people who suffer from chronic and infectious diseases which include diabetes and cardiovascular disorders and respiratory infections.

People who know about early disease detection and preventive healthcare methods create a positive effect on point-of-care diagnostics. The market expansion has received support from reimbursement policies that show favorable conditions while regulatory bodies back new diagnostic products. Market growth receives support from the major companies that exist in the industry as they spend on research development, which results in new products and technological progress.

The rising demand for home testing and remote patient monitoring systems together with telemedicine service expansion drive North America to use point-of-care devices more frequently. North America will keep its leading position in the Global Point-of-Care Diagnostics Market during the prediction period as healthcare systems in the region work to improve efficiency and patient access and develop patient-focused services.

Analysis of Key Players in Point-of-Care Diagnostics Market

Abbott, BD, Bio-Rad Laboratories, Inc., bioMérieux SA, Cardinal Health Inc., Danaher Corporation, EKF Diagnostics Holdings plc, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., Nova Biomedical, Quidel Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Trinity Biotech Plc., and the other prominent players are the key players governing the global Point-of-Care Diagnostics Market.

Each of these players has been profiled in the point-of-care diagnostics market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments

  • In May 2025, SEKISUI Diagnostics announced the launch of a new rapid diagnostic testing tool for detecting Respiratory Syncytial Virus (RSV) in professional healthcare settings.
  • In March 2025, Visby Medical announced that the U.S. Food and Drug Administration (FDA) granted De Novo authorization for the Visby Medical Women's Sexual Health Test for Over the Counter (OTC) use. This groundbreaking test enables reliable, rapid, and private at-home testing for Chlamydia, Gonorrhea, and Trichomoniasis-the three most common curable sexually transmitted infections (STIs).
  • In April 2025, DexCom, Inc. announced that the U.S. FDA had cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the U.S. With an overall MARD of 8.0%,3 Dexcom G7 15 Day builds on the performance of Dexcom CGM, which is clinically proven to lower A1C, reduce hyper- and hypoglycemia, and increase time in range

Point-of-Care Diagnostics Market Snapshot

Attribute Detail
Size in 2025 USD 19.1 Billion
Forecast Value in 2036 USD 43.7 Billion
CAGR 7.8%
Forecast Period 2026-2036
Historical Data Available for 2020-2024
Quantitative Units USD Billion for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape
  • Competition Matrix
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Segmentation By Product
  • Infectious Disease Testing Products
    • Influenza Testing Products
    • HIV Testing Products
    • Sexually Transmitted Disease Testing Products
    • Healthcare-associated Infection Testing Products
    • Others
  • Glucose Monitoring Products
  • Cardiometabolic Monitoring Products
  • Pregnancy & Fertility Testing Products
  • Coagulation Monitoring Products
  • Tumor/Cancer Marker Testing Products
  • Urinalysis Testing Products
  • Cholesterol Testing Products
  • Hematology Testing Products
  • Others
By Technology
  • Biochemistry
  • Immunoassay
  • Molecular Diagnostics
    • Polymerase Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
Mode of Purchase
  • Prescription-based Products
  • OTC Products
Sample
  • Blood
  • Urine
  • Nasal and Oropharyngeal Swabs
  • Others
End-user
  • Hospitals
  • Diagnostic Laboratories
  • Clinics/Physician Offices
  • Home Care
  • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • The Netherlands
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • ASEAN
  • Brazil
  • Mexico
  • Argentina
  • GCC Countries
  • South Africa
Companies Profiled
  • Abbott
  • BD
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Cardinal Health Inc.
  • Danaher Corporation
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson Services, Inc.
  • Nova Biomedical
  • Quidel Corporation
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech Plc.
  • Other Prominent Players
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global point-of-care diagnostics market in 2025?

The global point-of-care diagnostics market was valued at USD 19.1 Billion in 2025

What is the projected size of the point-of-care diagnostics market by 2036?

The global point-of-care diagnostics market is projected to cross USD 43.7 Billion by the end of 2036

What are the factors driving the point-of-care diagnostics market?

Rising prevalence of chronic and infectious diseases, increasing the demand for rapid and early diagnosis and increasing adoption of home-based testing and remote patient monitoring solutions.

What is the point-of-care diagnostics Industry expected to grow during the forecast period?

The global point-of-care diagnostics Industry is anticipated to grow at a CAGR 7.8% from 2026 to 2036

Which region is expected to dominate the point-of-care diagnostics market during the forecast period?

North America is expected to account for the largest share from 2026 to 2036

Who are the prominent point-of-care diagnostics providers?

Abbott, BD, Bio-Rad Laboratories, Inc., bioMérieux SA, Cardinal Health Inc., Danaher Corporation, EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Nova Biomedical, Quidel Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Trinity Biotech Plc, and the other prominent players

  1. Preface
    • Market Definition and Scope
    • Market Segmentation
    • Key Research Objectives
    • Research Highlights
  2. Assumptions and Research Methodology
  3. Executive Summary: Global Point-of-Care Diagnostics Market
  4. Market Overview
    • Introduction
      • Segment Definition
      • Industry Evolution / Developments
    • Overview
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Global Point-of-Care Diagnostics Market Analysis and Forecast, 2021-2036
      • Market Revenue Projections (US$ Bn)
  5. Key Insights
    • Healthcare Expenditure by Country/Region
    • Recent Technological Advancements
    • Regulatory Scenario across Key Countries / Regions
    • Porter’s Five Forces Analysis
    • Consumer Behavior & End-user Insights
    • PESTLE Analysis
    • Key Industry Events
    • Go to Marketing Strategies for New Entrants
    • Pricing Analysis
    • Distributors Landscape
  6. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Product
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Attractiveness Analysis, by Product
  7. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Technology
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Attractiveness Analysis, by Technology
  8. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Mode of Purchase
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Attractiveness Analysis, by Mode of Purchase
  9. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Sample
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Attractiveness Analysis, by Sample
  10. Global Point-of-Care Diagnostics Market Analysis and Forecast, by End-user
    • Introduction & Definition
    • Key Findings/Developments
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis, by End-user
  11. Global Point-of-Care Diagnostics Market Analysis and Forecast, by Region
    • Key Findings
    • Market Value Forecast, by Region, 2021-2036
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
    • Market Attractiveness Analysis, by Region
  12. North America Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Value Forecast, by Country, 2021-2036
      • U.S.
      • Canada
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
      • By Country
  13. U.S. Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  14. Canada Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  15. Europe Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • The Netherlands
      • Rest of Europe
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
      • By Country/Sub-region
  16. Germany Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  17. U.K. Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  18. France Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  19. Italy Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  20. Spain Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  21. The Netherlands Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  22. Rest of Europe Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  23. Asia Pacific Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • ASEAN
      • Rest of Asia Pacific
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
      • By Country/Sub-region
  24. China Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  25. India Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  26. Japan Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  27. South Korea Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  28. Australia Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  29. ASEAN Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  30. Rest of Asia Pacific Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  31. Latin America Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
      • By Country/Sub-region
  32. Brazil Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  33. Mexico Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  34. Argentina Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  35. Rest of Latin America Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  36. Middle East & Africa Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Value Forecast, by Country/Sub-region, 2021-2036
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
      • By Country/Sub-region
  37. GCC Countries Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  38. South Africa Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  39. Rest of Middle East & Africa Point-of-Care Diagnostics Market Analysis and Forecast
    • Introduction
      • Key Findings
    • Market Value Forecast, by Product, 2021-2036
      • Infectious Disease Testing Products
        • Influenza Testing Products
        • HIV Testing Products
        • Sexually Transmitted Disease Testing Products
        • Healthcare-associated Infection Testing Products
        • Others
      • Glucose Monitoring Products
      • Cardiometabolic Monitoring Products
      • Pregnancy & Fertility Testing Products
      • Coagulation Monitoring Products
      • Tumor/Cancer Marker Testing Products
      • Urinalysis Testing Products
      • Cholesterol Testing Products
      • Hematology Testing Products
      • Others
    • Market Value Forecast, by Technology, 2021-2036
      • Biochemistry
      • Immunoassay
      • Molecular Diagnostics
        • Polymerase Chain Reaction (PCR)
        • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Market Value Forecast, by Mode of Purchase, 2021-2036
      • Prescription-based Products
      • OTC Products
    • Market Value Forecast, by Sample, 2021-2036
      • Blood
      • Urine
      • Nasal and Oropharyngeal Swabs
      • Others
    • Market Value Forecast, by End-user, 2021-2036
      • Hospitals
      • Diagnostic Laboratories
      • Clinics/Physician Offices
      • Home Care
      • Others
    • Market Attractiveness Analysis
      • By Product
      • By Technology
      • By Mode of Purchase
      • By Sample
      • By End-user
  40. Competition Landscape
    • Market Player - Competition Matrix (By Tier and Size of Companies)
    • Market Share Analysis, by Company (2025)
    • Company Profiles
      • Abbott
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • BD
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • bioMérieux SA
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Cardinal Health Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Danaher Corporation
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • EKF Diagnostics Holdings plc
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • F. Hoffmann-La Roche Ltd.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Johnson & Johnson Services, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Nova Biomedical
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Quidel Corporation
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Siemens Healthcare GmbH
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Thermo Fisher Scientific, Inc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments
      • Trinity Biotech Plc.
        • Company Overview
        • Financial Overview
        • Product Portfolio
        • Business Strategies
        • Recent Developments

List of Tables

Table 01: Global Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 02: Global Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 03: Global Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 04: Global Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 05: Global Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 06: Global Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 07: Global Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 08: Global Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 09: North America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 10: North America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 11: North America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 12: North America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 13: North America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 14: North America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 15: North America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 16: North America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 17: U.S. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 18: U.S. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 19: U.S. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 20: U.S. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 21: U.S. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 22: U.S. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 23: U.S. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 24: Canada Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 25: Canada Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 26: Canada Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 27: Canada Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 28: Canada Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 29: Canada Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 30: Canada Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 31: Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 32: Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 33: Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 34: Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 35: Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 36: Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 37: Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 38: Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 39: Germany Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 40: Germany Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 41: Germany Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 42: Germany Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 43: Germany Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 44: Germany Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 45: Germany Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 46: U.K. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 47: U.K. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 48: U.K. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 49: U.K. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 50: U.K. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 51: U.K. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 52: U.K. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 53: France Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 54: France Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 55: France Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 56: France Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 57: France Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 58: France Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 59: France Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 60: Italy Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 61: Italy Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 62: Italy Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 63: Italy Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 64: Italy Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 65: Italy Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 66: Italy Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 67: Spain Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 68: Spain Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 69: Spain Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 70: Spain Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 71: Spain Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 72: Spain Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 73: Spain Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 74: The Netherlands Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 75: The Netherlands Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 76: The Netherlands Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 77: The Netherlands Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 78: The Netherlands Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 79: The Netherlands Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 80: The Netherlands Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 81: Rest of Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 82: Rest of Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 83: Rest of Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 84: Rest of Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 85: Rest of Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 86: Rest of Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 87: Rest of Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 88: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 89: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 90: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 91: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 92: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 93: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 94: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 95: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 96: China Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 97: China Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 98: China Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 99: China Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 100: China Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 101: China Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 102: China Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 103: Japan Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 104: Japan Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 105: Japan Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 106: Japan Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 107: Japan Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 108: Japan Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 109: Japan Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 110: India Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 111: India Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 112: India Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 113: India Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 114: India Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 115: India Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 116: India Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 117: South Korea Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 118: South Korea Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 119: South Korea Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 120: South Korea Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 121: South Korea Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 122: South Korea Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 123: South Korea Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 124: Australia Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 125: Australia Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 126: Australia Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 127: Australia Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 128: Australia Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 129: Australia Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 130: Australia Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 131: ASEAN Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 132: ASEAN Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 133: ASEAN Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 134: ASEAN Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 135: ASEAN Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 136: ASEAN Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 137: ASEAN Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 138: Rest of Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 139: Rest of Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 140: Rest of Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 141: Rest of Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 142: Rest of Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 143: Rest of Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 144: Rest of Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 145: Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 146: Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 147: Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 148: Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 149: Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 150: Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 151: Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 152: Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 153: Brazil Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 154: Brazil Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 155: Brazil Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 156: Brazil Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 157: Brazil Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 158: Brazil Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 159: Brazil Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 160: Mexico Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 161: Mexico Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 162: Mexico Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 163: Mexico Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 164: Mexico Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 165: Mexico Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 166: Mexico Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 167: Argentina Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 168: Argentina Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 169: Argentina Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 170: Argentina Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 171: Argentina Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 172: Argentina Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 173: Argentina Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 174: Rest of Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 175: Rest of Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 176: Rest of Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 177: Rest of Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 178: Rest of Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 179: Rest of Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 180: Rest of Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 181: Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 182: Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 183: Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 184: Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 185: Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 186: Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 187: Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 188: Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Country/Sub-region, 2021 to 2036
Table 189: GCC Countries Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 190: GCC Countries Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 191: GCC Countries Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 192: GCC Countries Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 193: GCC Countries Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 194: GCC Countries Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 195: GCC Countries Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 196: South Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 197: South Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 198: South Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 199: South Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 200: South Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 201: South Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 202: South Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036
Table 203: Rest of Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Product, 2021 to 2036
Table 204: Rest of Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Infectious Disease Testing Products, 2021 to 2036
Table 205: Rest of Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Technology, 2021 to 2036
Table 206: Rest of Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Molecular Diagnostics, 2021 to 2036
Table 207: Rest of Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Mode of Purchase, 2021 to 2036
Table 208: Rest of Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by Sample, 2021 to 2036
Table 209: Rest of Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, by End-user, 2021 to 2036

List of Figures

Figure 01: Global Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 02: Global Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 03: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 04: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Infectious Disease Testing Products, 2021 to 2036
Figure 05: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Glucose Monitoring Products, 2021 to 2036
Figure 06: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Cardiometabolic Monitoring Products, 2021 to 2036
Figure 07: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Pregnancy & Fertility Testing Products, 2021 to 2036
Figure 08: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Coagulation Monitoring Products, 2021 to 2036
Figure 09: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Tumor/Cancer Marker Testing Products, 2021 to 2036
Figure 10: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Urinalysis Testing Products, 2021 to 2036
Figure 11: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Cholesterol Testing Products, 2021 to 2036
Figure 12: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Hematology Testing Products, 2021 to 2036
Figure 13: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 14: Global Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 15: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 16: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Biochemistry, 2021 to 2036
Figure 17: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Immunoassay, 2021 to 2036
Figure 18: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Molecular Diagnostics, 2021 to 2036
Figure 19: Global Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 20: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 21: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Prescription-based Products, 2021 to 2036
Figure 22: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by OTC Products, 2021 to 2036
Figure 23: Global Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 24: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 25: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Blood, 2021 to 2036
Figure 26: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Urine, 2021 to 2036
Figure 27: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Nasal and Oropharyngeal Swabs, 2021 to 2036
Figure 28: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 29: Global Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 30: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 31: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Hospitals, 2021 to 2036
Figure 32: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Diagnostic Laboratories, 2021 to 2036
Figure 33: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Clinics/Physician Offices, 2021 to 2036
Figure 34: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Clinics/Physician Offices, 2021 to 2036
Figure 35: Global Point-of-Care Diagnostics Market Revenue (US$ Bn), by Others, 2021 to 2036
Figure 36: Global Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 37: Global Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 38: North America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 39: North America Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 40: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 41: North America Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 42: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 43: North America Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 44: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 45: North America Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 46: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 47: North America Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 48: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 49: North America Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 50: North America Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 51: U.S. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 52: U.S. Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 53: U.S. Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 54: U.S. Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 55: U.S. Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 56: U.S. Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 57: U.S. Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 58: U.S. Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 59: U.S. Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 60: U.S. Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 61: U.S. Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 62: Canada Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 63: Canada Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 64: Canada Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 65: Canada Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 66: Canada Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 67: Canada Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 68: Canada Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 69: Canada Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 70: Canada Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 71: Canada Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 72: Canada Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 73: Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 74: Europe Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 75: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 76: Europe Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 77: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 78: Europe Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 79: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 80: Europe Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 81: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 82: Europe Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 83: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 84: Europe Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 85: Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 86: Germany Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 87: Germany Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 88: Germany Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 89: Germany Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 90: Germany Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 91: Germany Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 92: Germany Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 93: Germany Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 94: Germany Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 95: Germany Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 96: Germany Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 97: U.K. Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 98: U.K. Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 99: U.K. Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 100: U.K. Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 101: U.K. Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 102: U.K. Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 103: U.K. Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 104: U.K. Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 105: U.K. Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 106: U.K. Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 107: U.K. Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 108: France Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 109: France Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 110: France Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 111: France Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 112: France Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 113: France Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 114: France Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 115: France Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 116: France Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 117: France Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 118: France Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 119: Italy Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 120: Italy Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 121: Italy Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 122: Italy Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 123: Italy Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 124: Italy Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 125: Italy Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 126: Italy Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 127: Italy Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 128: Italy Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 129: Italy Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 130: Spain Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 131: Spain Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 132: Spain Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 133: Spain Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 134: Spain Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 135: Spain Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 136: Spain Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 137: Spain Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 138: Spain Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 139: Spain Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 140: Spain Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 152: The Netherlands Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 153: The Netherlands Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 154: The Netherlands Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 155: The Netherlands Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 156: The Netherlands Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 157: The Netherlands Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 158: The Netherlands Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 159: The Netherlands Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 160: The Netherlands Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 161: The Netherlands Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 162: The Netherlands Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 163: Rest of Europe Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 164: Rest of Europe Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 165: Rest of Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 166: Rest of Europe Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 167: Rest of Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 168: Rest of Europe Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 169: Rest of Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 170: Rest of Europe Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 171: Rest of Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 172: Rest of Europe Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 173: Rest of Europe Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 174: Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 175: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 176: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 177: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 178: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 179: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 180: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 181: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 182: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 183: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 184: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 185: Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 186: Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 187: China Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 188: China Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 189: China Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 190: China Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 191: China Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 192: China Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 193: China Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 194: China Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 195: China Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 196: China Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 197: China Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 198: Japan Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 199: Japan Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 200: Japan Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 201: Japan Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 202: Japan Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 203: Japan Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 204: Japan Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 205: Japan Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 206: Japan Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 207: Japan Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 208: Japan Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 209: India Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 210: India Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 211: India Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 212: India Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 213: India Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 214: India Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 215: India Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 216: India Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 217: India Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 218: India Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 219: India Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 220: South Korea Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 221: South Korea Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 222: South Korea Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 223: South Korea Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 224: South Korea Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 225: South Korea Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 226: South Korea Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 227: South Korea Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 228: South Korea Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 229: South Korea Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 230: South Korea Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 231: Australia Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 232: Australia Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 233: Australia Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 234: Australia Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 235: Australia Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 236: Australia Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 237: Australia Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 238: Australia Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 239: Australia Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 240: Australia Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 241: Australia Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 242: ASEAN Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 243: ASEAN Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 244: ASEAN Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 245: ASEAN Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 246: ASEAN Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 247: ASEAN Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 248: ASEAN Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 249: ASEAN Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 250: ASEAN Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 251: ASEAN Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 252: ASEAN Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 242: Rest of Asia Pacific Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 243: Rest of Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 244: Rest of Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 245: Rest of Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 246: Rest of Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 247: Rest of Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 248: Rest of Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 249: Rest of Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 250: Rest of Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 251: Rest of Asia Pacific Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 252: Rest of Asia Pacific Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 253: Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 254: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 255: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 256: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 257: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 258: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 259: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 260: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 261: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 262: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 263: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 264: Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 265: Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 266: Brazil Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 267: Brazil Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 268: Brazil Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 269: Brazil Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 270: Brazil Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 271: Brazil Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 272: Brazil Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 273: Brazil Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 274: Brazil Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 275: Brazil Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 276: Brazil Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 277: Mexico Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 278: Mexico Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 279: Mexico Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 280: Mexico Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 281: Mexico Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 282: Mexico Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 283: Mexico Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 284: Mexico Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 285: Mexico Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 286: Mexico Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 287: Mexico Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 288: Argentina Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 289: Argentina Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 290: Argentina Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 291: Argentina Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 292: Argentina Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 293: Argentina Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 294: Argentina Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 295: Argentina Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 296: Argentina Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 297: Argentina Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 298: Argentina Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 299: Rest of Latin America Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 300: Rest of Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 301: Rest of Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 302: Rest of Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 303: Rest of Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 304: Rest of Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 305: Rest of Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 306: Rest of Latin America Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 307: Rest of Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 308: Rest of Latin America Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 309: Rest of Latin America Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 310: Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 311: Middle East and Africa Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 312: Middle East and Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 313: Middle East and Africa Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 314: Middle East and Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 315: Middle East and Africa Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 316: Middle East and Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 317: Middle East and Africa Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 318: Middle East and Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 319: Middle East and Africa Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 320: Middle East and Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 321: Middle East and Africa Point-of-Care Diagnostics Market Value Share Analysis, by Country/Sub-region, 2025 and 2036
Figure 322: Middle East and Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2026 to 2036
Figure 323: GCC Countries Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 324: GCC Countries Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 325: GCC Countries Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 326: GCC Countries Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 327: GCC Countries Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 328: GCC Countries Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 329: GCC Countries Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 330: GCC Countries Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 331: GCC Countries Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 332: GCC Countries Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 333: GCC Countries Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 334: South Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 335: South Africa Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 336: South Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 337: South Africa Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 338: South Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 339: South Africa Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 340: South Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 341: South Africa Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 342: South Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 343: South Africa Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 344: South Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036
Figure 345: Rest of Middle East and Africa Point-of-Care Diagnostics Market Value (US$ Bn) Forecast, 2021 to 2036
Figure 346: Rest of Middle East and Africa Point-of-Care Diagnostics Market Value Share Analysis, by Product, 2025 and 2036
Figure 347: Rest of Middle East and Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Product, 2026 to 2036
Figure 348: Rest of Middle East and Africa Point-of-Care Diagnostics Market Value Share Analysis, by Technology, 2025 and 2036
Figure 349: Rest of Middle East and Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Technology, 2026 to 2036
Figure 350: Rest of Middle East and Africa Point-of-Care Diagnostics Market Value Share Analysis, by Mode of Purchase, 2025 and 2036
Figure 351: Rest of Middle East and Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Mode of Purchase, 2026 to 2036
Figure 352: Rest of Middle East and Africa Point-of-Care Diagnostics Market Value Share Analysis, by Sample, 2025 and 2036
Figure 353: Rest of Middle East and Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by Sample, 2026 to 2036
Figure 354: Rest of Middle East and Africa Point-of-Care Diagnostics Market Value Share Analysis, by End-user, 2025 and 2036
Figure 355: Rest of Middle East and Africa Point-of-Care Diagnostics Market Attractiveness Analysis, by End-user, 2026 to 2036

Copyright © Transparency Market Research, Inc. All Rights reserved